---
title: "Eli Lilly Among Petitioners Denied Certiorari as Supreme Court Rejects Multiple Appeals"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286789989.md"
description: "Eli Lilly was among the pharmaceutical companies denied certiorari by the Supreme Court, which rejected multiple appeals related to healthcare and commercial cases. This decision diminishes the chances of immediate Supreme Court intervention in these matters. Following the news, Eli Lilly's shares fell by 2.2% to $985.25."
datetime: "2026-05-18T14:29:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286789989.md)
  - [en](https://longbridge.com/en/news/286789989.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286789989.md)
---

# Eli Lilly Among Petitioners Denied Certiorari as Supreme Court Rejects Multiple Appeals

10:29 AM EDT, 05/18/2026 (MT Newswires) -- Eli Lilly ( LLY ) was among the pharmaceutical firms highlighted in Monday's Supreme Court order list, which included widespread denials of certiorari in drugmaker-related and other commercial cases, according to the Court's May 18 orders.

The Court vacated and remanded several cases, including voting rights disputes, while rejecting review in multiple pharmaceutical and healthcare-related petitions, reducing the likelihood of near-term Supreme Court intervention in those matters.

The Court granted review in one education case while denying dozens of appeals across civil, criminal, regulatory, and healthcare matters, with Justice Sotomayor separately concurring in the denial of certiorari in a sentencing case in which relief had already been granted.

Shares of Eli Lilly ( LLY ) were down 2.2% in Monday trading.

Price: 985.25, Change: -19.68, Percent Change: -1.96

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

### Related Stocks

- [LLY.US](https://longbridge.com/en/quote/LLY.US.md)
- [LLYX.US](https://longbridge.com/en/quote/LLYX.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [ELIS.US](https://longbridge.com/en/quote/ELIS.US.md)
- [LLYZ.US](https://longbridge.com/en/quote/LLYZ.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [ELIL.US](https://longbridge.com/en/quote/ELIL.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [LABD.US](https://longbridge.com/en/quote/LABD.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)

## Related News & Research

- [Eli Lilly (LLY) Is the Face of the Obesity Boom. Has the Market Already Priced It In?](https://longbridge.com/en/news/286727957.md)
- [Trump purchased Eli Lilly stock as policies favored its drugs](https://longbridge.com/en/news/286791021.md)
- [US Supreme Court turns away Eli Lilly's challenge to whistleblower law](https://longbridge.com/en/news/286781378.md)
- [Eli Lilly (LLY) Is Up 6.0% After Obesity Drug Data And $4.5B Manufacturing Push - Has The Bull Case Changed?](https://longbridge.com/en/news/286629257.md)
- [Trump's Stock Picks Perfectly Timed With New Medicare Rules: Report](https://longbridge.com/en/news/286951567.md)